Jefferies analyst Joe Dickstein keeps a Buy rating and $57 price target on American Healthcare REIT (AHR) while naming the stock the firm’s Top Pick for 2026. The company stands out given its peer-leading exposure to RIDEA – REIT Investment Diversification and Empowerment Act – senior housing, the 2nd lowest cost of equity, and a growing investment pipeline, the analyst tells investors in a research note. The stock’s market cap also allows for greater earnings lift from acquisitions vs larger peers, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Completes Public Stock Offering
- American Healthcare REIT price target raised to $53 from $46 at Truist
- American Healthcare REIT Closes Public Stock Offering
- American Healthcare REIT 8.1M share Spot Secondary priced at $48.00
- American Healthcare REIT price target raised to $52 from $45 at Citi